The influence of cytokines on the complex pathology of ulcerative colitis - ScienceDirect
Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challeng | CEG
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remi
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis - Wang, Y - 2016 | Cochrane Library
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology
Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1. - Document - Gale OneFile:
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Cureus | Patterns of Complementary and Alternative Medicine Use in Saudi Arabian Patients With Inflammatory Bowel Disease: A Cross-Sectional Study
Mucosal gene expression in inflammatory bowel disease | CEG
PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Frontiers | Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020 | Journal of Investigative Medicine
Steroid Resistance/Dependence Might Be an Alarming Feature for Cytomegalovirus Infection Among Ulcerative Colitis Patients With
Frontiers | Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
![PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,](https://og.oa.mg/Infliximab%20is%20more%20effective%20than%20cyclosporine%20as%20a%20rescue%20therapy%20for%20acute%20severe%20ulcerative%20colitis:%20a%20retrospective%20single-center%20study.png?author=%20Marco%20Le%20Grazie,%20Siro%20Bagnoli,%20Gabriele%20Dragoni,%20Saverio%20Caini,%20Vito%20Annese,%20Tommaso%20Innocenti,%20Simona%20Deiana,%20Natalia%20Manetti,%20Stefano%20Milani,%20Andrea%20Galli,%20Monica%20Milla "PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,")
PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,
Full article: New treatment strategies for ulcerative colitis
2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two Parts - Page 11 of 11 - Tom Wade MD
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowe
Frontiers | Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options?
